{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:56:15Z","timestamp":1792439775598,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.chom.2020.07.007","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T10:44:36Z","timestamp":1597229076000},"page":"233-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":233,"title":["Microbiota and Fatty Liver Disease\u2014the Known, the Unknown, and the Future"],"prefix":"10.1016","volume":"28","author":[{"given":"Sonja","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2020.07.007_bib1","first-page":"855","article-title":"Effects of fecal microbiota transplantation with oral capsules in obese patients","volume":"18","author":"Allegretti","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterological Assoc."},{"key":"10.1016\/j.chom.2020.07.007_bib2","article-title":"An open label, dose escalation study to assess the safety and efficacy of IL-22 agonist","author":"Arab","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2020.07.007_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2020.07.007_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/joim.12508","article-title":"The gut microbiota and metabolic disease: current understanding and future perspectives","volume":"280","author":"Arora","year":"2016","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.chom.2020.07.007_bib5","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"B\u00e4ckhed","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2020.07.007_bib6","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2020.07.007_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02566-18","article-title":"Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers","volume":"10","author":"Baxter","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.chom.2020.07.007_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41424-018-0025-4","article-title":"Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects","volume":"9","author":"Bouter","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.chom.2020.07.007_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","article-title":"Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis","volume":"69","author":"Brandl","year":"2018","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chom.2020.07.007_bib10","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.chom.2020.07.007_bib11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1136\/gutjnl-2011-301689","article-title":"Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice","volume":"61","author":"Caesar","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.chom.2020.07.007_bib12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/hep.29892","article-title":"Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2020.07.007_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/apt.15035","article-title":"Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD","volume":"49","author":"Caussy","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.chom.2020.07.007_bib14","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/gutjnl-2014-307913","article-title":"Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults","volume":"64","author":"Chambers","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.chom.2020.07.007_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2019.09.029","article-title":"The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease","volume":"72","author":"Chu","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chom.2020.07.007_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/gutjnl-2018-316307","article-title":"Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease","volume":"68","author":"Chu","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.chom.2020.07.007_bib17","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/gast.2000.19267","article-title":"Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis","volume":"119","author":"Cope","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2020.07.007_bib18","doi-asserted-by":"crossref","first-page":"e0119362","DOI":"10.1371\/journal.pone.0119362","article-title":"Alcohol induced alterations to the human fecal VOC metabolome","volume":"10","author":"Couch","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.chom.2020.07.007_bib19","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/acer.12428","article-title":"Tributyrin supplementation protects mice from acute ethanol-induced gut injury","volume":"38","author":"Cresci","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.chom.2020.07.007_bib20","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2020.07.007_bib21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chom.2020.07.007_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.chom.2020.07.007_bib23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2018.08.022","article-title":"FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid","volume":"155","author":"Friedman","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2020.07.007_bib24","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fmicb.2017.01162","article-title":"Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity","volume":"8","author":"Gupta","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.chom.2020.07.007_bib25","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(18)30474-4","article-title":"NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"391","author":"Harrison","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2020.07.007_bib26","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.30590","article-title":"NGM282 improves liver fibrosis and histology in 12\u00a0weeks in patients with nonalcoholic steatohepatitis","volume":"71","author":"Harrison","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2020.07.007_bib27","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.29676","article-title":"Modulation of the intestinal bile acid\/farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice","volume":"67","author":"Hartmann","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2020.07.007_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40168-019-0689-3","article-title":"Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease","volume":"7","author":"Heinken","year":"2019","journal-title":"Microbiome"},{"key":"10.1016\/j.chom.2020.07.007_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.chom.2020.07.007_bib30","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","article-title":"Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice","volume":"68","author":"Hendrikx","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.chom.2020.07.007_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/joim.12892","article-title":"Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation","volume":"286","author":"Hendrikx","year":"2019","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.chom.2020.07.007_bib32","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2020.07.007_bib33","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.chom.2020.07.007_bib34","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.1323599111","article-title":"Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut","volume":"111","author":"Joyce","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2020.07.007_bib35","doi-asserted-by":"crossref","first-page":"11595","DOI":"10.1096\/fj.201901327R","article-title":"Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis","volume":"33","author":"Juanola","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.chom.2020.07.007_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3945\/ajcn.110.010132","article-title":"Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans","volume":"94","author":"Jumpertz","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.chom.2020.07.007_bib37","doi-asserted-by":"crossref","first-page":"G929","DOI":"10.1152\/ajpgi.00315.2013","article-title":"Colonic inflammation and secondary bile acids in alcoholic cirrhosis","volume":"306","author":"Kakiyama","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.chom.2020.07.007_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.chom.2020.07.007_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7975","article-title":"An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans","volume":"11","author":"Kurtz","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2020.07.007_bib40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/liv.14377","article-title":"Cytolysin-positive Enterococcus faecalis is not increased in patients with non-alcoholic steatohepatitis","volume":"40","author":"Lang","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.chom.2020.07.007_bib41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","article-title":"Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis","volume":"71","author":"Lang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2020.07.007_bib42","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2020.07.007_bib43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2018.6536","article-title":"National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States","volume":"179","author":"Lee","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.chom.2020.07.007_bib44","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.chom.2020.07.007_bib45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41467-017-00796-x","article-title":"Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus","volume":"8","author":"Llorente","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2020.07.007_bib46","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.30946","article-title":"The 20% rule of NASH progression: the natural history of advanced fibrosis and cirrhosis caused by NASH(6)","volume":"70","author":"Loomba","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2020.07.007_bib47","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.chom.2020.07.007_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1053\/jhep.2003.50116","article-title":"Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats(3)","volume":"37","author":"Lorenzo-Z\u00fa\u00f1iga","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2020.07.007_bib49","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1096\/fj.14-259515","article-title":"Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice","volume":"29","author":"Mazagova","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.chom.2020.07.007_bib50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2016.04.032","article-title":"Microbiome therapeutics\u2014advances and challenges","volume":"105","author":"Mimee","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chom.2020.07.007_bib51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fphys.2019.00185","article-title":"Intestinal bacteria interplay with bile and cholesterol metabolism: implications on host physiology","volume":"10","author":"Molinero","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.chom.2020.07.007_bib52","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chom.2020.07.007_bib53","doi-asserted-by":"crossref","first-page":"e0151829","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile acids and dysbiosis in non-alcoholic fatty liver disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.chom.2020.07.007_bib54","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/liv.13531","article-title":"Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD","volume":"38","author":"Nobili","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.chom.2020.07.007_bib55","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2019.05.020","article-title":"Natural history of histologically proven alcohol-related liver disease: a systematic review","volume":"71","author":"Parker","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chom.2020.07.007_bib56","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.chom.2020.07.007_bib57","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2020.07.007_bib58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12664-018-0859-4","article-title":"Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis","volume":"37","author":"Philips","year":"2018","journal-title":"Indian J. Gastroenterol."},{"key":"10.1016\/j.chom.2020.07.007_bib59","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41591-019-0559-3","article-title":"A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research","volume":"25","author":"Poyet","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2020.07.007_bib60","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease","volume":"6","author":"Rau","year":"2018","journal-title":"U.\u00a0Eur. Gastroenterol. J."},{"key":"10.1016\/j.chom.2020.07.007_bib61","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","article-title":"The role of the gut microbiome in chronic liver disease: the clinical evidence revised","volume":"1","author":"Schwenger","year":"2019","journal-title":"JHEP Rep."},{"key":"10.1016\/j.chom.2020.07.007_bib62","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/oby.2009.167","article-title":"Microbiota and SCFA in lean and overweight healthy subjects","volume":"18","author":"Schwiertz","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.chom.2020.07.007_bib63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ajcn\/nqz042","article-title":"Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"110","author":"Sharpton","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.chom.2020.07.007_bib64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hep.31178","article-title":"Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity","volume":"72","author":"Smirnova","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2020.07.007_bib65","author":"Synlogic"},{"key":"10.1016\/j.chom.2020.07.007_bib66","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.chom.2020.07.007_bib67","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.chom.2020.07.007_bib68","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/liv.12575","article-title":"Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease","volume":"35","author":"Voican","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.chom.2020.07.007_bib69","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2020.07.007_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.chom.2020.07.007_bib71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cell.2019.12.025","article-title":"Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents","volume":"180","author":"Walter","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.chom.2020.07.007_bib72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chom.2016.01.003","article-title":"Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation","volume":"19","author":"Wang","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2020.07.007_bib83","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.chom.2020.07.007_bib73","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2020.07.007_bib74","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.chom.2020.07.007_bib75","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: analysis from a Chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chom.2020.07.007_bib76","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chom.2020.07.007_bib77","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2020.07.007_bib78","doi-asserted-by":"crossref","first-page":"e1003051","DOI":"10.1371\/journal.pmed.1003051","article-title":"Fecal microbiota transplantation for the improvement of metabolism in obesity: the FMT-TRIM double-blind placebo-controlled pilot trial","volume":"17","author":"Yu","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.chom.2020.07.007_bib79","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae","volume":"30","author":"Yuan","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.chom.2020.07.007_bib80","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2020.07.007_bib81","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2020.07.007_bib82","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3389\/fmicb.2018.02247","article-title":"The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease","volume":"9","author":"Zuo","year":"2018","journal-title":"Front. Microbiol."}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312820304030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312820304030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:22:03Z","timestamp":1761826923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312820304030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1931312820304030"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2020.07.007","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota and Fatty Liver Disease\u2014the Known, the Unknown, and the Future","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2020.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}